Elevated Blood Pressure and Serum γ -Glutamyltransferase as Significant Characteristics of Smokers With Chronic Kidney Disease.

PubWeight™: 0.75‹?›

🔗 View Article (PMC 4317723)

Published in Nephrourol Mon on July 05, 2014

Authors

Yuka Noborisaka1, Masao Ishizaki1, Michiko Yamazaki1, Ryumon Honda1, Yuichi Yamada1

Author Affiliations

1: Department of Social and Environmental Medicine, Kanazawa Medical University School of Medicine, Uchinada, Japan.

Articles cited by this

Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis (2009) 18.60

The definition, classification, and prognosis of chronic kidney disease: a KDIGO Controversies Conference report. Kidney Int (2010) 9.25

Predictors of new-onset kidney disease in a community-based population. JAMA (2004) 7.45

Insulin resistance and cigarette smoking. Lancet (1992) 4.10

Increase in circulating products of lipid peroxidation (F2-isoprostanes) in smokers. Smoking as a cause of oxidative damage. N Engl J Med (1995) 3.91

Risk factors for chronic kidney disease in a community-based population: a 10-year follow-up study. Kidney Int (2006) 3.00

Plasma lipids and risk of developing renal dysfunction: the atherosclerosis risk in communities study. Kidney Int (2000) 2.85

Uric acid and incident kidney disease in the community. J Am Soc Nephrol (2008) 2.44

Significance of hyperuricemia on the early detection of renal failure in a cohort of screened subjects. Hypertens Res (2001) 2.35

Relationship between cigarette smoking and novel risk factors for cardiovascular disease in the United States. Ann Intern Med (2003) 2.22

Blood pressure in smokers and nonsmokers: epidemiologic findings. Am Heart J (1986) 2.04

gamma-Glutamyltransferase as a predictor of chronic kidney disease in nonhypertensive and nondiabetic Korean men. Clin Chem (2006) 1.94

Elevation of ambulatory systolic blood pressure in hypertensive smokers. A case-control study. JAMA (1991) 1.70

The risk of hypertension in men: direct and indirect effects of chronic smoking. J Hypertens (2002) 1.68

C-reactive protein as a predictor of disease in smokers and former smokers: a review. Int J Clin Pract (2009) 1.66

Insulin resistance and compensatory hyperinsulinemia: the key player between cigarette smoking and cardiovascular disease? J Am Coll Cardiol (2003) 1.58

Cigarette smoking increases sympathetic outflow in humans. Circulation (1998) 1.54

Effects of smoking cessation on blood pressure and heart rate variability in habitual smokers. Hypertension (1999) 1.47

Is serum gamma-glutamyltransferase inversely associated with serum antioxidants as a marker of oxidative stress? Free Radic Biol Med (2004) 1.36

Renal manifestations in the metabolic syndrome. J Am Soc Nephrol (2006) 1.33

Inflammation in chronic kidney disease: role in the progression of renal and cardiovascular disease. Pediatr Nephrol (2008) 1.29

Structural, functional, and clinical aspects of gamma-glutamyltransferase. CRC Crit Rev Clin Lab Sci (1980) 1.21

Changes after quitting cigarette smoking. Circulation (1980) 1.11

Triglyceride, but not total cholesterol or low-density lipoprotein cholesterol levels, predict development of proteinuria. Kidney Int (2002) 1.10

Oxidants in the gas phase of cigarette smoke pass through the lung alveolar wall and raise systemic oxidative stress. J Pharmacol Sci (2007) 1.09

Relationship between serum gamma-glutamyltransferase and chronic kidney disease in the United States adult population. Findings from the National Health and Nutrition Examination Survey 2001-2006. Nutr Metab Cardiovasc Dis (2009) 1.00

Facilitated nitration and oxidation of LDL in cigarette smokers. Eur J Clin Invest (2005) 1.00

The differential effect of cigarette smoking on glomerular filtration rate and proteinuria in an apparently healthy population. Hypertens Res (2009) 0.91

Chronic kidney disease, dyslipidemia, and atherosclerosis. J Atheroscler Thromb (2011) 0.89

Smoking and chronic kidney disease in healthy populations. Nephrourol Mon (2012) 0.89

Early effects of smoking cessation and weight gain on plasma adiponectin levels and insulin resistance. Intern Med (2011) 0.87

Effect of tobacco smoking and smoking cessation on plasma lipoproteins and associated major cardiovascular risk factors: a narrative review. Curr Med Res Opin (2013) 0.87

Serum uric Acid in smokers. Oman Med J (2008) 0.84

The effects of continuing and discontinuing smoking on the development of chronic kidney disease (CKD) in the healthy middle-aged working population in Japan. Environ Health Prev Med (2012) 0.84

Ambulatory blood pressure monitoring for evaluating the relationships between lifestyle, hypertension and cardiovascular risk. Clin Exp Pharmacol Physiol (1995) 0.84

Association between serum gamma-glutamyltransferase and oxidative stress related factors. Hepatogastroenterology (2008) 0.83

Elevated Serum Gamma-Glutamyltransferase (GGT) Activity and the Development of Chronic Kidney Disease (CKD) in Cigarette Smokers. Nephrourol Mon (2013) 0.79

Serum gamma-glutamyl transpeptidase: a prognostic marker in cardiovascular diseases. Biofactors (2003) 0.79

Association between smoking, pancreatic insulin secretion and insulin resistance in Chinese subjects with or without glucose intolerance. Chin Med J (Engl) (2007) 0.78